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ABSTRACT 37 
Objectives. Carotid artery reactivity (CAR%), involving carotid artery diameter responses to 38 
a cold pressor test, is a non-invasive measure of conduit artery function in humans. This study 39 
examined: 1. the impact of age and cardiovascular risk factors on the CAR% and 2. The 40 
relationship between CAR% and coronary artery vasodilator responses to the cold pressor 41 
test.  42 
Methods. Ultrasound was used to measure resting and peak carotid artery diameters during 43 
the cold pressor test, with CAR% being calculated as the relative change from baseline (%). 44 
We compared CAR% between young (n=50, 24±3 years) and older participants (n=44, 61±8 45 
years), and subsequently assessed relationships between CAR% and traditional cardiovascular 46 
risk factors in 50 participants (44±21 years). Subsequently, we compared left anterior 47 
descending (LAD) artery velocity (using transthoracic Doppler) with carotid artery diameter 48 
(i.e. CAR%) during the cold pressor test (CPT, n=33, 37±17 years). 49 
Results. A significantly larger CAR% was found in young versus older healthy participants 50 
(4.1±3.7 versus 1.8±2.6, P<0.001). Participants without cardiovascular risk factors 51 
demonstrated a higher CAR% compared to those with ≥2 risk factors (2.9±2.9 versus 0.5±2.9, 52 
P=0.019). Carotid artery diameter and LAD velocity increased during CPT (P<0.001). 53 
Carotid diameter and change in velocity correlated with LAD velocity (r=0.486 and 0.402, 54 
P<0.004 and 0.02, respectively). 55 
Conclusion. Older age and cardiovascular risk factors are related to lower CAR%, whilst 56 
CAR% shows good correlation with coronary artery responses to the CPT. Therefore, CAR% 57 
may represent a valuable technique to assess cardiovascular risk, whilst CAR% seems to 58 
reflect coronary artery vasodilator function.  59 
 60 
KEYWORDS: Endothelial function, coronary arteries, carotid artery reactivity test, cold 61 
pressor test, cardiovascular risk  62 
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INTRODUCTION 63 
Previous studies have explored the impact of stimulation of the sympathetic nervous system, 64 
using the cold pressor test (CPT), on coronary artery responses.
1-3
 Coronary artery responses 65 
to CPT are suggested to be endothelium-dependent.
4
 Whilst coronary dilation is observed in 66 
healthy volunteers, participants with CV risk or disease demonstrate attenuated dilation or 67 
even constriction during the CPT.
2, 4-8
 Moreover, CPT-induced constriction of coronary 68 
arteries independently predicts future cardiovascular (CV) events.
9
 Non-invasive assessment 69 
of coronary artery diameter, however, is currently technically challenging, expensive and 70 
lacks sufficient temporal resolution to assess rapid changes in diameter.  71 
 72 
Similar to coronary arteries, CPT may dilate carotid artery in asymptomatic older participants, 73 
whereas significant constriction is present in those with coronary heart disease.
10
 No previous 74 
study examined whether the magnitude of response (i.e. dilation or constriction) of the carotid 75 
artery reactivity (CAR%) to the CPT is altered by older age and/or presence of cardiovascular 76 
risk factors. Furthermore, given similarity in vascular responsiveness between coronary and 77 
carotid arteries to CPT, with opposite responses between healthy participants (i.e. dilation) 78 
versus patients with coronary heart disease (i.e. constriction),
9, 10
 one may question whether a 79 
correlation exists between coronary and carotid artery responses to the CPT, such as described 80 
previously for other measures of peripheral vascular function.
11-16
 This would provide the first 81 
study to assess whether CAR% directly relates to coronary artery vascular function. 82 
 83 
This study aims to better understand the potential clinical relevance of CAR% as a putative 84 
marker of cardiovascular risk and surrogate for coronary artery function. First, we examined 85 
the hypothesis that older age and increasing number of traditional cardiovascular risk factors 86 
(e.g. blood pressure, cholesterol, hypertension, diabetes, and smoking) are associated with a 87 
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smaller CAR% in healthy, asymptomatic participants. Secondly, we explored the relation 88 
between coronary artery and carotid artery responses to the CPT in healthy, asymptomatic 89 
participants. This work will provide important information to determine if the carotid and 90 
coronary arteries exhibit similar functional responses in the presence of cardiovascular risk 91 
factors and disease. 92 
 93 
 94 
METHODS 95 
Participants 96 
We recruited 94 healthy participants without clinical presentation of atherosclerosis.  97 
Exclusion criteria were a history of cardiovascular disease (i.e. angina, myocardial infarction, 98 
and heart failure), presence of Raynaud's phenomenon, scleroderma, chronic pain and/or open 99 
wounds on the upper extremities. Written informed consent was obtained from all participants 100 
prior to participation. Ethical approval was obtained from local Ethics committee (Aim 1: 101 
Radboud university medical centre, Aim 2: Liverpool John Moores University), in accordance 102 
with the latest revision of the Declaration of Helsinki. 103 
 104 
Experimental design 105 
All participants (n=94) reported to our laboratory for a single visit. Participants were asked to 106 
abstain from strenuous exercise for 24 hours, fast for ≥6 hours, and to abstain from dietary 107 
products known to alter endothelial function for ≥18 hours prior to the testing sessions (i.e. 108 
caffeine, vitamin C) according to guidelines to assess peripheral vascular function.
17
 Upon 109 
arrival, weight (kg) and height (cm) were measured and participants rested in the supine 110 
position for at least 15 minutes on a comfortable bed in a temperature-controlled room. All 111 
subjects underwent the CPT, involving continuous ultrasonography measurements of the 112 
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carotid artery diameter and velocity as well as haemodynamics at baseline (1-min) and during 113 
(3-min) CPT. Peak changes in diameter during CPT, presented as the relative change from 114 
baseline, represents the CAR%. To reduce measurement error, procedures were repeated after 115 
1 h and averaged for analyses. For Aim 1 (i.e. relationship CAR% & risk factors), we divided 116 
the entire study population (n=94) into young (n=50, age range 19-30 years) and older adults 117 
(n=44, age range 50-82 years). Cardiovascular risk profile was assessed in 50 participants 118 
(Radboud university medical centre, 44±21 years), who were divided in subjects with 0, 1 or 119 
≥2 cardiovascular risk factors. These different subgroups are presented in Figure 1.  120 
 121 
For Aim 2 (i.e. CAR% vs coronary artery velocity), we studied a subgroup of 44 participants 122 
(Liverpool John Moores University), and simultaneously examined carotid artery diameter 123 
and left anterior descending coronary artery velocity responses using Doppler ultrasound 124 
during the CPT. Due to technical constraints 11 participants were excluded from analysis. 125 
This left us with 33 participants to assess the relation between CAR% and coronary artery 126 
velocity responses to the CPT (37±17 years).   127 
 128 
Experimental measures 129 
Cold pressor test. The CPT consisted of a 3-minute immersion of the left hand in a bucket of 130 
ice slush (~4.0ºC). The participant was positioned supine on a comfortable bed, facilitating 131 
arm movement of the left hand into the bucket of ice slush without significant movement of 132 
the neck to enable assessment of the carotid and coronary arteries. After a 1-minute baseline 133 
period, the participant immersed the hand up to the wrist in the ice slush for 3 minutes. The 134 
participant was instructed not to speak and breathe normally (to prevent hyperventilation) 135 
when the hand was submerged into the ice slush. 136 
 137 
Van Mil et al. Relation CAR with cardiovascular risk & coronaries 
7 
 
Carotid artery diameter, blood flow and shear rate. Participants were positioned with the 138 
neck extended to allow assessment of the carotid artery. Left carotid artery diameter and red 139 
blood cell velocity were recorded continuously during baseline (1-minute) and CPT (3-140 
minutes) with a 10-MHz linear array handheld probe attached to a high resolution ultrasound 141 
machine (Terason T3000, Aloka, United Kingdom). When an optimal image was found, the 142 
probe was held stable and the ultrasound parameters were set to optimise the longitudinal, B-143 
mode image of the lumen-arterial wall interface. Continuous pulsed wave Doppler velocity 144 
assessments were also obtained and were collected at the lowest possible insonation angle 145 
(always <60º). Following a 1-minute baseline assessment of carotid artery diameter and 146 
velocity, the hand was immersed for 3-minutes with simultaneous and continuous assessment 147 
of carotid artery diameter and velocity.  148 
 149 
Intima-media thickness. Previous studies found carotid artery intima-media thickness (IMT) 150 
to relate to cardiovascular risk and predict future cardiovascular disease.
18
 To explore the 151 
relevance of studying CAR% and IMT, we included measurements of the IMT (mm) of the 152 
left common carotid artery. According to widely adopted recommendations, we measured the 153 
IMT approximately 2cm proximal to the bulbus. We recorded the IMT continuously for 10 154 
seconds, in 2 different perpendicular planes (differing 90º).  From the 2 measurements wall 155 
thickness was calculated. Analyses were performed with edge-detection and wall-tracking 156 
software, as described elsewhere.
19
  157 
 158 
Blood pressure and heart rate. Before and during CPT, we continuously measured blood 159 
pressure using non-invasive photoplethysmography (Aim 1: Nexfin, BMEYE, Amsterdam, 160 
The Netherlands, Aim 2: Portapress, Finapres Medical Systems, Amsterdam, Netherlands).  161 
 162 
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Cardiovascular risk factors (Aim 1; CAR% vs Risk factors). For the subgroups of 50 163 
participants, we performed additional assessment of cardiovascular risk factors. To examine 164 
systolic and diastolic blood pressure, we performed two assessments of blood pressure using 165 
the manual approach (sphygmomanometer, on the left arm). Hypertension was defined as 166 
systolic pressure ≥140mmHg and/or diastolic pressure ≥90mmHg.20 We reported diagnosis of 167 
type 1 or 2 diabetes mellitus and recorded (past and current) smoking habits. We used 168 
capillary blood to assess total cholesterol, high density lipoprotein cholesterol, low density 169 
lipoprotein cholesterol and triglycerides (35µL blood, Mission, ACON Laboratories, Inc., San 170 
Diego, USA). Elevated cholesterol levels were defined as total cholesterol >5.0 mmol/L.
21-23
 171 
Based on the presence of risk factors, these participants were subdivided in; i. 0 risk factors, 172 
ii. 1 risk factor, and iii. ≥2 risk factors.  173 
 174 
Coronary artery responses (Aim 2; CAR% vs coronary artery). In a subgroup of 33 175 
participants (37±17 years), left anterior descending (LAD) coronary artery velocity responses 176 
to the CPT were examined using transthoracic ultrasound, during simultaneous assessment of 177 
the CAR. Transthoracic assessment was performed by a highly experienced sonographer 178 
using a Vivid Q (GE Medical, Horten, Norway), with a 4 MHz phased array transducer. To 179 
this end, participants assumed a slightly left lateral position to allow access and measurement 180 
of the proximal end of the LAD from a modified parasternal window. When the vessel was 181 
detected (using color flow mapping), the Doppler sample volume was positioned in the 182 
vessel, to allow for real-time velocity assessment during the cardiac cycle. Acquisition of the 183 
coronary velocity was obtained at baseline and during CPT.
24
  184 
 185 
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Data analysis 186 
Carotid artery diameter, velocity, blood flow and shear rate. CAR% responses were assessed 187 
for both diameter and blood flow. Analysis of the carotid artery diameter was performed 188 
using custom-designed edge-detection and wall-tracking software, which is largely 189 
independent of investigator bias, by a single blinded investigator.
25
 Details of this technique 190 
can be found elsewhere.
26
 Baseline diameter, velocity, shear rate,
25
 and blood flow were 191 
calculated as the mean of data acquired across the 1 minute preceding the CPT test. After 192 
submersion of the hand in ice slush, data were calculated as the mean value for 10-second 193 
intervals, involving 8-10 full cardiac cycles. Based on this data we calculated the peak 194 
diameter change (i.e. the 10-second bin with the highest value, CAR%) and area-under-the-195 
curve for the diameter change during CPT (CARAUC). The peak diameter change can refer to a 196 
maximum constriction or dilation. The direction of this change was determined by a positive 197 
(i.e. dilation) or negative (i.e. constriction) CARAUC. In keeping with previous work, we also 198 
calculated the diameter change at 90 seconds (CAR90).
17
 Reproducibility (coefficient of 199 
variation, CV) of diameter responses to CPT was assessed with a 1- and 24-hour interval. 200 
Within-day CV for baseline and peak diameters was 2.2 and 2.6%, whilst day-to-day CV 201 
were 2.3% and 2.7%. Furthermore, the CAR% (i.e. maximum change in diameter) showed a 202 
within-day reproducibility of 2.6% and between-day reproducibility of 2.8%. 203 
 204 
Blood pressure and heart rate. Analyses included baseline and peak mean arterial pressure 205 
(MAP, mmHg), and baseline and peak heart rate (HR, beats per minute). Analyses were 206 
performed in labchart (LabChart 7, ADInstruments, Colorado Springs, USA) and/or excel. 207 
Both MAP and HR were averaged per 30 second bins for analyses. All values were averaged 208 
over the 2 CPTs.   209 
 210 
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Coronary artery responses. All images were exported to DVD in raw format, for offline 211 
analyses.  The coronary blood velocity was analysed using commercially available software 212 
(EchoPAC Version 7.0; GE Medical, Horten, Norway). Measurements were performed at 213 
both baseline and during CPT and included peak systolic (S), peak diastolic (D) velocity and 214 
the velocity time integral (VTI).  215 
 216 
Statistical analysis 217 
All data were presented as mean ± SD unless stated otherwise. Statistical analysis was done 218 
using IBM SPSS Statistics 20.0 (IBM SPSS, IBM Corp., Armonk, NY, USA).  For Aim 1, we 219 
examined differences between young and older groups using an independent Students’ t-tests 220 
(when data were normally distributed, following Kolmogorov-Smirnov tests of normality) or 221 
Mann-Whitney U tests (when data was not normally distributed). Effects of CPT differences 222 
between the groups (young vs older, and 0 vs 1 vs ≥2 risk factors) and time (baseline vs CPT) 223 
was assessed by 2-way repeated measures ANOVAs. Subsequently, 50 individuals with 224 
assessment of traditional cardiovascular risk factors were categorised into presence of 0, 1 or 225 
≥2 cardiovascular risk factors. A one-way ANOVA (data normally distributed) or Kruskal-226 
Wallis (data not normally distributed) was adopted to examine differences in our primary 227 
outcome parameters between groups. A Pearson’s correlation was adopted to assess the 228 
relation between CAR% (i.e. carotid artery function) and carotid artery intima-media 229 
thickness and diameter (i.e. carotid artery structure). For Aim 2, we first examined the change 230 
in carotid artery diameter and LAD velocity in response to CPT using a paired Student’s t-231 
tests. Pearsons’ correlation coefficient was used to explore the relation between the change in 232 
carotid artery diameter (i.e. CAR%) and change in coronary artery velocity (i.e. VTI).  233 
 234 
 235 
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RESULTS 236 
In healthy young subjects, CPT caused a gradual increase in carotid artery diameter that 237 
peaked around 90 seconds and, subsequently, returned towards baseline (Figure 2A). Carotid 238 
artery velocity and blood flow showed a gradual (~15%), but significant increase across the 3-239 
minutes of the CPT-response (Figure 2B-C). Interestingly, shear rate remained around 240 
baseline levels until 90/100 seconds, after which it showed a marginal (~10%) increase 241 
(Figure 2D). 242 
 243 
Aim 1: CAR% versus cardiovascular risk factors 244 
Young and older participants. Older participants demonstrated higher weight and BMI, but no 245 
differences in height (Table 1). Systolic and diastolic blood pressure were higher in older 246 
compared to young participants (Table 1). Mean arterial pressure was lower in young 247 
compared to the older group, whilst heart rate was not different between groups (Table 2). 248 
Carotid artery diameter was larger in the older group than in young participants, whilst carotid 249 
artery shear rate was higher in the young group (Table 2). CPT induced a significant increase 250 
in heart rate and mean arterial pressure in both groups, with older participants demonstrating a 251 
larger increase in heart rate and a larger increase in mean arterial pressure (Table 2). Both 252 
groups demonstrated a significant increase in carotid artery diameter in response to the CPT 253 
(Table 2). The diameter response during the CPT was significantly larger in young compared 254 
to older humans when data were presented as the peak diameter change (i.e. CAR%), area-255 
under-the-curve across the 3-minute CPT (i.e. CARAUC) and diameter change at 90-seconds 256 
(i.e. CAR90) (Table 2, Figure 3A).  257 
 258 
Cardiovascular risk factors. Cholesterol and LDL levels were highest in those with 1 RF 259 
compared to 0 or ≥2 RF, whilst no differences between groups were found for any of the other 260 
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parameters (Table 3). We found a significantly different CAR%, CARAUC and CAR90 across 261 
the 3 groups (Figure 3B, Table 3), with a smaller carotid artery dilation observed in the 262 
presence of more cardiovascular risk factors. Specifically, we found that participants with ≥2 263 
risk factors showed a smaller dilation compared to those without risk factors (Table 3). In line 264 
with the CAR%, carotid artery diameter, IMT, and IMT ratio (i.e. intima-media 265 
thickness/baseline diameter) were higher in participants with more risk factors (Table 3). 266 
However, no significant correlation was found between CAR% and carotid artery baseline 267 
diameter (r= -0.16, P=0.274), IMT (r= -0.09, P=0.524), or IMT ratio (r= -0.06, P=0.678). 268 
 269 
Aim 2: CAR% versus coronary artery 270 
The CPT caused a significant increase in heart rate, mean arterial pressure, and carotid artery 271 
flow, velocity and shear rate (Table 4). A significant increase in carotid artery diameter was 272 
found when presented as CAR%, CARAUC and CAR90 (Table 4). Furthermore, a significant 273 
increase in LAD velocity was found during the CPT (Table 4). We found a significant, 274 
positive correlation between the CAR% and the change in LAD velocity time integral 275 
(r=0.486, P<0.004, Figure 4). A significant, positive correlation was also found between 276 
changes in carotid artery velocity and flow, and the change in LAD velocity time integral 277 
(r=0.402, P=0.021, and r=0.368, P=0.035, respectively). This relation between carotid and 278 
coronary artery responses was reinforced when data were presented as CAR90, but not for 279 
CARAUC (r=0.361 and 0.258, P=0.039 and 0.146, respectively).  280 
 281 
 282 
DISCUSSION 283 
In this study we explored the relationship between age, cardiovascular risk factors and CAR% 284 
and whether carotid artery responses to CPT reflect coronary artery vascular function. We 285 
found that the CPT induces carotid artery dilation in healthy, asymptomatic young 286 
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participants, with no changes in shear rate. This highlights the ability of the carotid artery to 287 
dilate in response to the CPT, a functional change that is unlikely to be related to shear-288 
mediated responses, as the dilation response of the carotid artery preceded any change in 289 
shear. Secondly, the CAR% was significantly attenuated in healthy, asymptomatic older 290 
participants, whilst presence of traditional cardiovascular risk factors was also associated with 291 
a smaller CAR%. These findings cannot be ascribed to structural characteristics of the carotid 292 
artery diameter (i.e. diameter or intima-media thickness), given the absence of a significant 293 
correlation between CAR% and these factors. Finally, a moderate-to-strong correlation was 294 
apparent between carotid artery dilation (i.e. diameter and velocity) and coronary artery 295 
dilator (i.e. velocity) responses to the CPT. These observations provide evidence that the 296 
CAR%, most likely independent of carotid artery structural characteristics, may represent a 297 
valuable test to assess arterial function and health and that it reflects coronary artery 298 
vasomotor function.  299 
 300 
Our study reveals the novel observation that, in a healthy, asymptomatic population, who 301 
generally demonstrate carotid artery dilation in response to the CPT, the CAR% successfully 302 
distinguishes between subjects with incremental number of risk factors. Also carotid artery 303 
IMT and diameter, both predictors for CV risk,
18
 were different between groups, with a higher 304 
value for those with ≥2 traditional cardiovascular risk factors. Since we found no correlation 305 
between CAR% and carotid IMT or diameter, it is possible that CAR% provides information 306 
that is independent from that of measures of carotid artery structure (i.e. diameter and IMT). 307 
This observation provides further support that CAR% may represent relevant information on 308 
CV risk. 309 
 310 
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Ideally, a test of (peripheral) vascular function related to CV risk should also reflect vascular 311 
health of coronary vessels, since coronary arteries are prone to the development of 312 
atherosclerosis and cardiovascular events. Previous studies have explored the relationship 313 
between measures of coronary and peripheral artery vascular function.
14, 16
 In line with these 314 
studies, carotid artery and coronary artery responses to the CPT show a moderate-to-strong 315 
correlation, a finding that is reinforced by earlier cross-study observations of comparable 316 
coronary and carotid artery responses to the CPT; dilation in healthy subjects or constriction 317 
in those with coronary artery disease.
2, 4, 10
 The ability for marked vasomotion of the carotid 318 
artery during the CPT is different to peripheral conduit arteries that typically show negligible 319 
change in diameter.
27, 28
 This further highlights the potential relevance for studying the carotid 320 
artery as a surrogate for coronary artery vascular function, since both of these conduit vessels 321 
demonstrate similar responses to the CPT. The agreement between the coronary and carotid 322 
artery responses to the CPT somewhat contrasts with the lack of correlation between 323 
measures of carotid artery atherosclerosis (i.e. intima-media thickness) and coronary artery 324 
atherosclerosis (i.e. plaque burden).
18
 Our data, nonetheless, suggest that functional, rather 325 
than structural, measures in the two vascular beds may be related. 326 
 327 
The ability of the carotid artery to dilate (or constrict) during the CPT raises questions 328 
regarding the potential underlying mechanisms. Whilst no extant study has examined the 329 
carotid artery, several studies explored pathways contributing to coronary artery vasomotion 330 
to the CPT.
1, 2, 4, 6-9, 29
 First, the diameter change to the CPT may be endothelium-dependent, 331 
since coronary artery responses to the CPT and acetylcholine (i.e. an endothelium-dependent 332 
stimulus) show similarity in vasomotion.
4, 29
 To explain diameter response to the CPT, an 333 
increase in shear stress during CPT may contribute to an endothelium-dependent 334 
vasodilation.
30
 However, the increase in shear rate during CPT occurred after occurrence of 335 
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the peak diameter (Figure 2), making changes in shear an unlikely explanation for carotid 336 
artery dilation. Another possibility is that the increase in blood pressure accounts for the 337 
diameter response to CPT. Indeed, we found a relation between increase in MAP and CAR%. 338 
However, the magnitude of increase in MAP did not differ between groups, whilst an increase 339 
in MAP was also observed in those who demonstrate a decrease in CAR%. This suggests that 340 
the increase in MAP is unlikely causally linked to carotid diameter changes. This notion is 341 
further supported when examining the timing of the peak responses, since peak diameter 342 
precede peak blood pressure responses by ~30 seconds. Nonetheless, we cannot exclude the 343 
possibility that increases in blood pressure contribute (partly) to the CAR%. Alternatively, the 344 
release of catecholamines during the CPT may contribute to vasomotion of the carotid artery 345 
during CPT,
31, 32
 with some work linking catecholamines (e.g. norepinephrine [NE]) to 346 
coronary artery dilation in healthy vessels or constriction in diseased arteries.
2, 29
 More 347 
specifically, NE may contribute to vasodilation via endothelium-dependent release of 348 
vasodilators,
1, 33
 whilst a direct impact of NE on smooth muscle cells causes 349 
vasoconstriction.
34, 35
 The balance between both effects may ultimately determines the 350 
vasomotor response, which could be influenced by endothelium dysfunction. Although these 351 
mechanisms were explored in coronary arteries, comparable mechanisms may be present in 352 
the carotid artery during the CPT. Further research is required to characterize the physiology 353 
of the carotid artery responses to sympathetic stimulation using the CPT.  354 
   355 
Clinical relevance. Previous studies adopting invasive intracoronary Doppler catheters
2, 4, 29
 356 
and quantitative angiography,
2, 4, 9, 29
 have shown strong predictive capacity of coronary artery 357 
responses to sympathetic stimuli for future CV disease and/or events.
6, 7, 9
 Our observation of 358 
agreement between coronary and carotid artery responses to the CPT, combined with the 359 
relation of the CAR% with age and cardiovascular risk factors, suggest the potential utility of 360 
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the CAR% test. This is further supported by the observation that the CAR% provides 361 
information that seems independent from that of structural measures of the carotid artery, i.e. 362 
diameter and intima-media thickness. The potential use is further emphasised since it is easy 363 
applicable, simple, cheap, non-invasive, and requiring a minimum of training. 364 
 365 
Limitations. We choose to group the number of cardiovascular risk factors, rather than 366 
explore the impact of individual risk factors, on the CAR%. Examining all individual risk 367 
factors would require a markedly larger sample size to properly perform statistical analyses, 368 
whilst our aim was to explore the relation between cardiovascular risk factors and the newly 369 
introduced CAR% in asymptomatic subjects. We strongly recommend future studies to 370 
explore the impact of individual risk factors to better understand how traditional risk factors 371 
affect CAR%. Secondly, due to technical restrictions, we were unable to collect LAD 372 
diameter to correlate diameter changes between both arteries. Since changes in diameter will 373 
affect measures of velocity, we may have underestimated the true correlation between both 374 
arteries in response to the CPT. Nonetheless, the significant correlation between both vascular 375 
beds, including the significant correlation between carotid artery and coronary artery 376 
velocities, emphasises the agreement between coronary and carotid responses to the CPT. 377 
 378 
In conclusion, in the present study we found that older age and the presence of cardiovascular 379 
risk factors is related to a lower CAR%. Therefore, CAR% may represent a valuable 380 
technique to assess cardiovascular risk, which may be used in addition to structural measures 381 
of the carotid artery (i.e. diameter and intima-media thickness). In addition, the CAR% shows 382 
a good correlation with coronary artery responses to the CPT, which suggests that the CAR% 383 
represents a surrogate for coronary artery vasomotor function.  384 
 385 
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FIGURE LEGENDS 498 
FIGURE 1.   Flow diagram to provide insight into the different subgroups to answer the 3 499 
aims.  500 
FIGURE 2. The time course presented during the cold pressor test in a young healthy 501 
subpopulation (n=25). A; diameter over time (cm), B; flow velocity over time 502 
(m/sec), and C; blood flow (ml/min) and D; shear over time (s
-1
). Error bars 503 
represent SEM. 504 
FIGURE 3. Carotid artery reactivity (CAR%, presented as maximal change from baseline) in 505 
a cohort of healthy, asymptomatic subjects that were divided based on age (A: 50 506 
young (black bar) versus 44 older humans (white bar)) and presence of 507 
cardiovascular risk factors (B: 0 risk factors (black bar, n=27), 1 risk factor (grey 508 
bar, n=11), and ≥2 risk factors (white bar, n=12)). Error bars represent SE. 509 
Statistical analysis (unpaired Students’ t-test (A) and ANOVA (B)) revealed 510 
significant differences in CAR% between groups. 511 
FIGURE 4. Correlation between the carotid artery diameter response (% maximum change 512 
from baseline; i.e. CAR%) and coronary left descending artery velocity response 513 
(change in the velocity time integral (VTI in cm)) during a cold pressor test in a 514 
population of healthy, asymptomatic participants (n=33). A significant, positive 515 
correlation was observed between both measurements.  516 
  517 
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Table 1. Subject characteristics for the comparison between young (19-30 years, n=50) and 518 
older (>50 years, n=44) participants. P-value refers to an unpaired Student’s t-test or *Mann-519 
Whitney U test for the comparison between young and older participants. 520 
    Young Older P-value 
Sex (% male) 56% 64% 0.452 
Age (years) 24±3 61±8 <0.001 
Weight (kg) 69±12 77±13 0.003 
Height (m) 174±8 172±8 0.100* 
Body Mass Index (kg/m
2
) 23±3 26±4 <0.001* 
Systolic blood pressure (mmHg) 118±9 134±19 <0.001* 
Diastolic blood pressure (mmHg) 68±8 78±7 <0.001 
     521 
 522 
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Table 2. Carotid artery and hemodynamic baseline characteristics (averaged across a 1-minute period) and change during the cold pressor test 523 
(averaged across the 3-minute cold pressor test) in young (19-30 years, n=50) and older (>50 years, n=44) participants. P-values refer to 2-way 524 
repeated measures ANOVA's, for within participant comparison (CPT), between group comparison (group), and the interaction Group*CPT. 525 
*Refers to Mann-Whitney U test. 526 
 
Young Older 2-way ANOVA 
 
Rest CPT Rest CPT group CPT Group*CPT 
MAP (mmHg) 85±13 95±14 102±15 114±18 <0.001 <0.001 0.063 
HR (bpm) 64±12 65±11 59±9 64±10 0.073 <0.001 0.006 
Diameter (mm) 6.3±0.5 6.5±0.5 7.1±0.7 7.2±0.8 <0.001 <0.001 <0.001 
Shear rate (1/s) 184±43 186±43 143±42 141±47 <0.001 0.905 0.318 
Flow (ml/min) 9.2±2.3 10.1±2.6 10.2±2.8 10.3±3.5 0.286 0.001 0.019 
Carotid artery reactivity (CAR) 
      
Diameter change (CAR%) 4.1±3.7 1.8±2.6 
 
<0.001* 
 
Diameter area-under-the-curve (CARAUC) 2.7±2.3 1.0±1.3  
<0.001 
 
Diameter change at 90 sec (CAR90) 3.5±2.8 1.4±1.6  
<0.001 
 
 527 
Van Mil et al. Relation CAR with cardiovascular risk & coronaries 
26 
 
Table 3. Carotid artery reactivity (CAR%, presented as maximal change from baseline) in a 528 
cohort of healthy, asymptomatic subjects categorised by the presence of cardiovascular risk: 529 
1. 0 risk factors (n=27), 2. 1 risk factor (n=11), and 3. ≥2 risk factors (n=12).*Post-hoc 530 
significantly different from group 1.†Refers to Kruskall-Wallis test. 531 
 
0 risk factors 
(N=27) 
1 risk factor 
(N=11) 
≥2 risk factors 
(N=12) 
P-value 
Sex (% male) 
 
52% 55% 42% 0.794 
Hypertension (%) - 9% 17% 0.115 
Diabetes (%) - - 8% 0.312 
Smoking (%)             Current 
 
- 9% 17% 0.139 
                               No 
 
89% 64% 58% 
 
                               History 
 
11% 27% 25%   
Cholesterol (mmol/L) 
 
4.25±0.7 6.17±1.4 5.5±1.3 >0.001† 
HDL (mmol/L) 
 
1.39±0.3 1.30±0.4 1.24±0.2 0.408 
LDL (mmol/L) 
 
2.59±0.7 4.0±1.5 3.4±1.4 0.025 
Triglycerides (mmol/L) 
 
1.3±1.0 2.1±1.3 1.9±1.1 0.196 
Baseline diameter (cm) 0.64±0.06 0.70±0.04* 0.74±0.08* >0.001 
Intima-media thickness (mm) 0.60±0.2 0.75±0.1* 0.82±0.1* 0.001 
IMT ratio 0.09±0.02 0.11±0.02 0.11±0.02* 0.036 
Carotid artery reactivity (CAR) 
 
CAR% 
 
 
2.9±2.9 2.3±2.2 0.5±2.9* 0.060 
CARAUC 
 
1.9±1.6 1.1±1.2 0.5±1.5* 0.034 
CAR90 
 
2.5±2.2 1.4±1.4 0.9±1.7* 0.037 
 532 
HDL; High density lipoprotein, LDL; Low density lipoprotein.   533 
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Table 4. Coronary artery responses in all participants included for Aim 2 (n=33). P-value 534 
refers to a paired Student’s t-test. *Refers to Wilcoxon Signed rank test.  535 
  Rest CPT P-value 
Mean arterial pressure (mmHg) 87±14 99±16 <0.001 
Heart rate (bpm) 60±10 62±10 0.048 
CA diameter (cm) 0.66±0.08 0.68±0.08 <0.001 
CA shear rate (1/s) 158±46 174±43 <0.001 
CA flow (ml/min) 9.1±2.7 10.9±3.4 <0.001 
CA velocity (cm/s) 25.8±6.7 29.3±7.1 <0.001 
LAD systolic velocity (cm/s) 15±3.5 18±3.4 <0.001* 
LAD diastolic velocity (cm/s) 31±7 39±9 <0.001 
LAD velocity time integral (cm/s) 17±4 20±4 <0.001 
Diameter change (CAR%) 
  
4.5±3.8   
Diameter area-under-the-curve (CARAUC) 2.8±2.5 
 
Diameter change at 90 sec (CAR90) 3.6±2.9 
 
Delta VTI (cm) 
  
2.7±2.3   
 536 
  537 
Van Mil et al. Relation CAR with cardiovascular risk & coronaries 
28 
 
 538 
 539 
  540 
Van Mil et al. Relation CAR with cardiovascular risk & coronaries 
29 
 
 541 
 542 
  543 
Van Mil et al. Relation CAR with cardiovascular risk & coronaries 
30 
 
  544 
Van Mil et al. Relation CAR with cardiovascular risk & coronaries 
31 
 
 545 
